Dr Tom Stratford CEO Kelso Pharma

Apposite Capital-backed Kelso Pharma acquires Stirling Anglian Pharmaceuticals

Mark McIntyre Kelso Pharma

Apposite Capital, the healthcare specialist private equity investor, and Kelso Pharma today (12th January 2022) announce the acquisition of Stirling Anglian Pharmaceuticals Limited. Kelso Pharma is headed by Dr Tom Stratford, previously CEO of Kyowa Kirin International (“KKI”), the European and US business arm of Kyowa Kirin, which purchased Scottish Borders based ProStrakan Group PLC in 2011. He is joined …